Abstract
The effect of tumour and all its related costs, both human and commercial factor is driving the exploration for novel curative medicines.Although platinum-based anticancer drugs have shown considerable success, their use is complicated by a number of drawbacks. Therefore, this study is mainly designed for transition metal complex based chemotherapeutic agents to reduce the obstacles for platinum-based anticancer agents presently used. Herein, novel mixed ligand-metal(II) complexes derived from 9-anthraldehyde, 2-aminophenol, metal chlorides and 1,10-phenanthroline (co-ligand) were synthesized and characterized using several spectral techniques, which revealed that they possess an octahedral structure. The interaction of calf thymus DNA (CT-DNA) with synthesized compounds confirmed that the compounds are binded with DNA via intercalation. The mode of interaction was affirmed by the docking simulations, where the synthesized compounds were docked with EGFR protein and 1B-DNA through intercalation. The biological screening results revealed that the synthesized complexes exhibited superior anti-pathogenic screening properties compared to ligands. The proliferation resistance against cancer cells and free radical scavenger studies of prepared compounds indicated that the presence of heterocyclic ligand is an important factor for boosting the anticancer potential and radical scavenger skill.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
